These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28752555)

  • 1. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.
    Raebel MA; Dyer W; Nichols GA; Goodrich GK; Schmittdiel JA
    Pharmacotherapy; 2017 Oct; 37(10):1204-1214. PubMed ID: 28752555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.
    Tjia J; Briesacher BA
    J Am Geriatr Soc; 2008 Oct; 56(10):1879-86. PubMed ID: 18771456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens.
    Kim HJ; Kim E; Min KB; Min JY
    Curr Med Res Opin; 2017 Feb; 33(2):385-390. PubMed ID: 27819152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers associated with lower risk of COVID-19 in household contacts.
    Armstrong K; Soltoff A; Rieu-Werden M; Metlay J; Haas J
    PLoS One; 2021; 16(3):e0247548. PubMed ID: 33651840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.
    Hurwitz JT; Grizzle AJ; Augustine J; Rehfeld R; Wild A; Abraham I
    J Manag Care Spec Pharm; 2016 Jan; 22(1):40-8. PubMed ID: 27015050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.
    Erlandson KM; Kitch D; Wester CW; Kalayjian RC; Overton ET; Castillo-Mancilla J; Koletar SL; Benson CA; Campbell TB; Robertson K; Lok JJ
    Clin Infect Dis; 2017 Nov; 65(12):2042-2049. PubMed ID: 29020174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Medication Day-Supply for Improving Adherence and Clinical Biomarkers of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein.
    Ameli N; Jones WN
    J Pharm Pract; 2024 Feb; 37(1):140-145. PubMed ID: 36154517
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.
    De Spiegeleer A; Bronselaer A; Teo JT; Byttebier G; De Tré G; Belmans L; Dobson R; Wynendaele E; Van De Wiele C; Vandaele F; Van Dijck D; Bean D; Fedson D; De Spiegeleer B
    J Am Med Dir Assoc; 2020 Jul; 21(7):909-914.e2. PubMed ID: 32674818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Medication Management and Medication Adherence for Chronic Conditions.
    Brummel A; Carlson AM
    J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes.
    Mohan A; Majd Z; Johnson ML; Essien EJ; Barner J; Serna O; Gallardo E; Fleming ML; Ordonez N; Holstad MM; Abughosh SM
    Drugs Aging; 2023 Apr; 40(4):377-390. PubMed ID: 36847995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus.
    Syed ST; Sharp LK; Kim Y; Jentleson A; Lora CM; Touchette DR; Berbaum ML; Suda KJ; Gerber BS
    Pharmacotherapy; 2016 Jun; 36(6):590-7. PubMed ID: 27087250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness.
    Owen-Smith A; Stewart C; Green C; Ahmedani BK; Waitzfelder BE; Rossom R; Copeland LA; Simon GE
    Gen Hosp Psychiatry; 2016; 38():9-14. PubMed ID: 26423559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    J Am Pharm Assoc (2003); 2010; 50(4):527-31. PubMed ID: 20621872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.